---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-072602"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2026-06-26T20:05:43+00:00"
generated_at: "2026-06-26T20:07:43.124433+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CERo Therapeutics enters amended convertible note for $1.4M; conversion price floor $0.05, 10% interest

## Summary
- Amended and restated promissory note with SRX Health Solutions for up to $1,413,600; $663,600 funded on June 23, 2026, on top of $750,000 from May 28 note.
- Note bears 10% annual interest, matures May 28, 2027; convertible into common stock at the lesser of $0.05 or 80% of avg of 5 lowest intraday prices in prior 20 days.
- Conversion subject to 4.99% beneficial ownership limitation; Company to file resale registration statement for shares issuable upon conversion.
- Issuance exempt from registration under Section 4(a)(2) and Rule 506(b); Note and underlying shares unregistered.

## SEC filing metadata
- accession: 0001213900-26-072602
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2026-06-26T20:05:43+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390026072602/0001213900-26-072602-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390026072602/ea0296022-8k_cero.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-072602
- JSON: https://secwatch.observer/filing/0001213900-26-072602.json
- Plain text: https://secwatch.observer/filing/0001213900-26-072602.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.